Evidence map›Paper›PMID 36654852›Full record

ArticleJournal of translational autoimmunity2023

Polyautoimmunity in systemic lupus erythematosus patients: New insights from a cross-sectional study.

Pedro Santos-Moreno, Julián Arias-Aponte, Gabriel-Santiago Rodríguez-Vargas, Paula Daniela Nieto-Zambrano, Laura Villarreal, Linda Ibatá, Susan Martinez, Jaime-Andrés Rubio-Rubio, Pedro Rodríguez, Adriana Rojas-Villarraga

Open access · goldAbstract read
In one paragraph

Article in Journal of translational autoimmunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Polyautoimmunity and multiple autoimmune syndromes: A neglected clinical challenge.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Article
  5. Review
  6. Article
  7. The autoimmune tautology revisited.Journal of translational autoimmunity · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Pedro Santos-MorenoScientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., 110221, Colombia.
Julián Arias-AponteResearch Vice-rectory, Fundación Universitaria de Ciencias de La Salud-FUCS, Bogotá D.C, 111411, Colombia.
Gabriel-Santiago Rodríguez-VargasScientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., 110221, Colombia.
Paula Daniela Nieto-ZambranoScientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., 110221, Colombia.
Laura VillarrealMedical Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., 110221, Colombia.
Linda IbatáEpidemiology, Biomab IPS, Bogotá, D.C, 110221, Colombia.
Susan MartinezEpidemiology, Biomab IPS, Bogotá, D.C, 110221, Colombia.
Jaime-Andrés Rubio-RubioResearch Institute, Fundación Universitaria de Ciencias de La Salud FUCS, Bogotá, D.C, 111411, Colombia.
Pedro RodríguezScientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., 110221, Colombia.
Adriana Rojas-VillarragaResearch Institute, Fundación Universitaria de Ciencias de La Salud FUCS, Bogotá, D.C, 111411, Colombia.
Center for Rheumatology · USFundación Universitaria de Ciencias de la Salud · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the frequency of polyautoimmunity (PolyA) in a cohort of Colombian patients with systemic lupus erythematosus (SLE) and to identify associated factors. Methods: This is an analytical cross-sectional study in a specialized center., a comprehensive review of the medical records of SLE patients was performed from 2015 to 2020 in order to obtain demographic, clinical data, laboratory, and treatment information. Associations between PolyA, demographic, and characteristics of the disease were explored. Results: A total of 463 patients were included in the analysis. The average age was 47.3 ± 15 years. Most of this population were female (87.4%), whom were diagnosed with SLE in a long-term SLE (10.6 ± 10.1 years). Out of the total patients, 34.7% were diagnosed with PolyA. Among the most frequent clinical criteria for SLICC, arthritis (65%), kidney impairment (39.5%), and alopecia (34.8%) were found. The most frequent SLE-associated PolyA were antiphospholipid syndrome (APS) and Sjögren's syndrome (SS) (16.63% and 10.58%, respectively). PolyA-associated factors were age, xerophthalmia, central nervous system occlusion, and deep vein thrombosis (DVT). In contrast, renal impairment was significantly less frequent in PolyA patients after multivariate analysis. Conclusion: The results have showed associated factors with PolyA like age, xerophthalmia, central nervous system occlusion, and deep vein thrombosis in this cohort. On the other hand, lupus nephritis was less frequent in patients with PolyA. This study provides a spotlight of a specific SLE population as real-life evidence for a better characterization of PolyA in the future.

Indexed as

Autoimmune diseasesEpidemiologyPolyautoimmunitySystemic lupus erythematosus

Identifiers

PMID36654852
PMCPMC9841268
OpenAlexW4313529743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.